This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

12 Stocks to Watch: Orexigen, Walter Energy

NEW YORK ( TheStreet) -- Orexigen Therapeutics (OREX - Get Report) is restarting development of its rejected obesity drug Contrave after U.S. regulators agreed to allow the company to conduct a potentially shorter follow-up clinical trial.

Shares were soaring 72.1% to $2.53.

Shares of Walter Energy (WLT) were plunging 11.5% to $66.40 after the metallurgical coal producer said a slower-than-expected recovery from the 100-year record rainfall experienced in Northeast British Columbia during the second quarter and slower-than-expected recovery from the difficult geology experienced at Mine No. 7 in Alabama will cause a delay in the company's anticipated production growth and associated improvement in savings.

Shares of Alpha Natural Resources (ANR) were tumbling 7.5% to $24.90 after the coal producer lowered its full-year shipment guidance to a range of 102.5 million tons to 109.5 million tons compared with the previous range of 104 million tons to 112 million tons.

Software make Adobe (ADBE - Get Report) edged Wall Street's profit expectations for its third quarter. The company reported earnings of $273 million, or 55 cents a share, with revenue coming in at $1.01 billion, up from $990.3 million in the same period a year earlier.

Shares were jumping 6.4% to $26.22.

Oracle (ORCL - Get Report) deftly sidestepped weakness in the global economy to post solid first-quarter revenue and earnings after markets closed on Tuesday.

The database software maker brought in revenue of $8.43 billion and earnings of 48 cents a share, up from $7.5 billion and 42 cents a share in the prior year's quarter. Analysts surveyed by Thomson Reuters were looking for sales of $8.35 billion and earnings of 46 cents a share.

Shares were adding 4.1% to $29.50.

Equity real estate investment trust Realty Income (O - Get Report) has begun an underwritten public offering of 6 million common shares.

Shares were down 2.4% to $33.61.

Independent energy company Apache (APA - Get Report) said its subsidiary Apache North Sea Ltd. agreed to buy Exxon Mobil's (XOM - Get Report) Mobil North Sea assets, including the Beryl field and related properties, for $1.75 billion.

Apache shares were down 0.3% to $94.25, and Exxon shares were down 0.3% to $73.80.

Microsoft (MSFT - Get Report) hiked its dividend, citing the company's recent strong performance.

The software maker's board declared a quarterly dividend of 20 cents a share, an increase of 4 cents, or 25%, on the prior quarter's dividend.

Shares were trading sideways at $26.99.

Boeing (BA - Get Report) is in "very advanced discussions" with Chinese airlines to revitalize sales of its 787 Dreamliner, according to a Wall Street Journal report.

PharMerica (PMC - Get Report), a national provider of pharmacy and hospital pharmacy management services, said its board voted unanimously to reject the unsolicited offer made by Omnicare (OCR) to buy the company for $15 a share in cash.

Food giant General Mills (GIS - Get Report) said first-quarter earnings declined but adjusted profit of 64 cents a share matched year-earlier results. Analysts surveyed by Thomson Reuters were expecting General Mills to earn 62 cents a share.

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

Related links:

Copyright 2011 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WLT $0.00 0.00%
ANR $0.04 3.17%
ADBE $92.94 0.00%
APA $50.73 0.00%
BA $130.89 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs